Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

PATHWAY ONTOLOGY - ANNOTATIONS

The Pathway Ontology (PW), is currently being developed at the Rat Genome Database. For more information about this vocabulary, please see Petri et al. The rat genome database pathway portal. Database (Oxford). 2011 Apr 8;2011:bar010. Print 2011 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Term:capecitabine pharmacokinetics pathway
go back to main search page
Accession:PW:0002132 term browser browse the term
Definition:The pathway of processing - absorption, distribution, metabolism or elimination - of capecitabine. Genetic variations can result in changes in the availability of the drug.
Synonyms:related_synonym: SMP:00607


show annotations for term's descendants           Sort by:
capecitabine pharmacokinetics pathway term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CDA cytidine deaminase EXP SMPDB SMP:00607 NCBI chr 1:20,589,097...20,618,903
Ensembl chr 1:20,589,086...20,618,903 		JBrowse link
G CES1 carboxylesterase 1 EXP SMPDB SMP:00607 NCBI chr16:55,802,851...55,833,096
Ensembl chr16:55,802,851...55,833,337 		JBrowse link
G SLC28A1 solute carrier family 28 member 1 EXP SMPDB SMP:00607 NCBI chr15:84,884,662...84,975,649
Ensembl chr15:84,884,654...84,945,798 		JBrowse link
G TYMP thymidine phosphorylase EXP SMPDB SMP:00607 NCBI chr22:50,525,752...50,530,085
Ensembl chr22:50,525,752...50,530,032 		JBrowse link
G TYMS thymidylate synthetase EXP SMPDB SMP:00607 NCBI chr18:657,653...673,578
Ensembl chr18:657,653...673,578 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  pathway 5958
    drug pathway 412
      antineoplastic and immunomodulatory drug pathway 160
        antineoplastic drug pathway 159
          capecitabine drug pathway 5
            capecitabine pharmacokinetics pathway 5
paths to the root